Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol 100/50mcg DISKUS® BID or Fluticasone Propionate 100mcg DISKUS® BID Alone
Brief Summary: This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic visits will include physical examination, medical history review and lung function tests. The purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is better in reducing the number of asthma exacerbations compared with another drug (fluticasone propionate alone)


Options:
A: Arm Label: Fluticasone furoate 50mcg; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone furoate 50mcg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fluticasone furoate 50mcg; Assigned to Arm(s): Fluticasone furoate 50mcg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Fluticasone/ Formoterol (Flutiform); Type: EXPERIMENTAL; Interventions: Drug: Fluticasone/ Formoterol | Arm Label: Fluticasone/ salmeterol (Seretide); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone/ salmeterol | Intervention Type: DRUG; Name: Fluticasone/ Formoterol; Assigned to Arm(s): Fluticasone/ Formoterol (Flutiform) | Intervention Type: DRUG; Name: fluticasone/ salmeterol; Assigned to Arm(s): Fluticasone/ salmeterol (Seretide)
C: Arm Label: GSK573719 15.6 mcg; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 31.25 mcg; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 62.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 125 mcg; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 250 mcg; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 15.6 mcg twice-daily; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: GSK573719 31.25 mcg twice daily; Type: EXPERIMENTAL; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Arm Label: Matched Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: GSK573719 Active treatment or Placebo, Procedure: GSK573719 (Sub-group cohort), Drug: Salbutamol/Albuterol | Intervention Type: DRUG; Name: GSK573719 Active treatment or Placebo; Assigned to Arm(s): GSK573719 125 mcg, GSK573719 15.6 mcg, GSK573719 15.6 mcg twice-daily, GSK573719 250 mcg, GSK573719 31.25 mcg, GSK573719 31.25 mcg twice daily, GSK573719 62.5 mcg, Matched Placebo | Intervention Type: PROCEDURE; Name: GSK573719 (Sub-group cohort); Assigned to Arm(s): GSK573719 125 mcg, GSK573719 15.6 mcg, GSK573719 15.6 mcg twice-daily, GSK573719 250 mcg, GSK573719 31.25 mcg, GSK573719 31.25 mcg twice daily, GSK573719 62.5 mcg, Matched Placebo | Intervention Type: DRUG; Name: Salbutamol/Albuterol; Assigned to Arm(s): GSK573719 125 mcg, GSK573719 15.6 mcg, GSK573719 15.6 mcg twice-daily, GSK573719 250 mcg, GSK573719 31.25 mcg, GSK573719 31.25 mcg twice daily, GSK573719 62.5 mcg, Matched Placebo
D: Intervention Type: DRUG; Name: fluticasone propionate/salmeterol powder; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: fluticasone propionate powder; Assigned to Arm(s): N/A

Answer: D